Study identifier:SD-037-0724
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Comparison of formoterol (Oxis) via Turbuhaler with salbutamol via pressurised metered dose inhaler and spacer in patients with acute asthma presenting to the Accident and Emergency Department
asthma
Phase 3
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|